The FDA cleared an automated insulin delivery system for use by pregnant women with type 1 diabetes, according to an industry ...

The FDA has cleared Tandem’s Control-IQ technology as the first ever AID specifically for use in pregnancies complicated by ...

Touchscreen insulin pump maker Tandem Diabetes announced a new clinical trial for an insulin pump with a predictive low glucose suspend (PLGS) algorithm. Another step on the road to an artificial ...

Abbott Laboratories has taken a big step in diabetes management by integrating its glucose sensor with a Tandem insulin pump, creating a hybrid closed-loop insulin delivery system. The two companies ...

Abbott’s latest innovation, the FreeStyle Libre® 2 Plus sensor, is available for the first time for t:slim X2™ insulin pump users in the U.S. Tandem’s Control-IQ™ hybrid closed-loop technology now ...

Abbott Laboratories is linking its continuous glucose monitoring with automated insulin delivery by entering a global partnership with health tech giant Medtronic. The pairing of Abbott's leading ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Tandem t:slim X2 insulin pump can now integrate with ...

Tandem Diabetes Care (TNDM) begins global commercial rollout of t:slim X2 pump integration with the FreeStyle Libre 3 Plus CGM sensor, expanding choice and personalization for people living with ...

Tandem Diabetes Care has received the Food and Drug Administration’s green light for the Tandem Mobi insulin pump for people with diabetes aged 6 years old and older. The Tandem Mobi is fully ...

The FDA has approved Insulet SmartAdjust automatic insulin dosing technology for type 2 diabetes in those aged 18 and older. The interoperable automated glycemic controller software connects to an ...